The results showed that the levels of the 40 cytokines, including IL6, IFN-γ, and TNF-γ, had no significant difference among the four treatment groups (Figures 3D, 4D), suggesting that cytokine release syndrome (CRS) do not occur during the treatment. This evidence concerns the gene IL6 and congenital rubella syndrome.